EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lack of association between prior or concurrent malignancies and overall survival in gastroesophageal cancer: evidence from a large European single-center cohort

Hannah C Puhr, Luzia Berchtold, Linda Zingerle, Martin Korpan, Julia M Berger, Gerd Jomrich, Reza Asari, Sebastian F Schoppmann, Gerald W Prager, Elisabeth S Bergen, Anna S Berghoff, Matthias Preusser und 1 weitere

Clinical and Translational Oncology · 2025

DOI: 10.1007/s12094-025-04036-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Oncology, 2025. Verfasst von Hannah C Puhr und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine I, Division of Oncology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Stomach Neoplasms, Neoplasms, Multiple Primary. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Vienna.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

History of malignant disease is a common exclusion criterion in clinical cancer trials, yet data on the impact of cancer survivorship on outcome in gastroesophageal cancer patients are scarce.

Methods

Retrospective association analyses of self-reported prior or concurrent malignancies with patient characteristics, tumor characteristics, symptoms and overall survival (OS) were performed in 1491 gastroesophageal cancers patients treated between 01/01/2000 and 31/12/2021 at the Medical University of Vienna.

Results

Of 1491 patients 255 (18%) had other primary cancer diagnoses, of which 185 (73%) occurred before, 52 (20%) at the same time as and 18 (7%) both before and at the same time as gastroesophageal cancer diagnosis. 205 (80%) patients had one, 43 (17%) had 2 and 7 (3%) had 3 other malignancies. History of other malignancies was associated with older age (p < 0.0001), squamous cell histology (p = 0.018), less aggressive localized tumor stages (p = 0.037) and fewer acid reflux (p = 0.011). There was neither an association between history of other primary malignancies nor the number of other cancer entities and OS (p = 0.47; p = 0.43).

Conclusion

Self-reported history of other malignant diseases is frequent in a real-life European gastroesophageal cancer cohort and was not statistically significantly associated with outcome, but rather with older age and squamous cell histology. Our data emphasize that cancer survivors should not be categorically excluded from clinical cancer trials due to fear of dismal prognosis. Prospective research is warranted to improve eligibility for this subgroup.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal NeoplasmsStomach NeoplasmsNeoplasms, Multiple PrimaryHumansMaleFemaleMiddle AgedRetrospective StudiesAgedSurvival RateEuropeAged, 80 and overAdultCohort StudiesPrognosis

Stichwörter der Autor:innen

Esophageal cancerGastric cancerOther malignanciesSurvivorship

Autor:innen und Institutionen

  • Department of Medicine I, Division of Oncology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
  • Christian Doppler Laboratory for Personalized Immunotherapy, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
  • Institute of Medical Statistics, Center for Medical Data Science, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
  • Department of Surgery, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
  • Department of Medicine I, Division of Oncology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. aysegul.ilhan@meduniwien.ac.at.
  • Christian Doppler Laboratory for Personalized Immunotherapy, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. aysegul.ilhan@meduniwien.ac.at.

Förderung

  • Medical University of Vienna

Zitieren

APA

Puhr, H. C., Berchtold, L., Zingerle, L., Korpan, M., Berger, J. M., Jomrich, G., Asari, R., Schoppmann, S. F., Prager, G. W., Bergen, E. S., Berghoff, A. S., Preusser, M., & Ilhan-Mutlu, A. (2025). Lack of association between prior or concurrent malignancies and overall survival in gastroesophageal cancer: evidence from a large European single-center cohort. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-025-04036-3

Vancouver

Puhr HC, Berchtold L, Zingerle L, Korpan M, Berger JM, Jomrich G, et al. Lack of association between prior or concurrent malignancies and overall survival in gastroesophageal cancer: evidence from a large European single-center cohort. Clinical and Translational Oncology. 2025. doi:10.1007/s12094-025-04036-3

BibTeX
@article{Puhr2025,
  author = {Puhr, Hannah C and Berchtold, Luzia and Zingerle, Linda and Korpan, Martin and Berger, Julia M and Jomrich, Gerd and Asari, Reza and Schoppmann, Sebastian F and Prager, Gerald W and Bergen, Elisabeth S and Berghoff, Anna S and Preusser, Matthias and Ilhan-Mutlu, Aysegül},
  title = {Lack of association between prior or concurrent malignancies and overall survival in gastroesophageal cancer: evidence from a large European single-center cohort},
  journal = {Clinical and Translational Oncology},
  year = {2025},
  doi = {10.1007/s12094-025-04036-3}
}
Kostenlos starten →